Wait a second!
More handpicked essays just for you.
More handpicked essays just for you.
Pathophysiology of.copd
Exacerbation of copd case study
Exacerbation of copd case study
Don’t take our word for it - see why 10 million students trust us with their essay needs.
Recommended: Pathophysiology of.copd
This assignment will examine the case of a man admitted to hospital with an exacerbation of chronic obstructive pulmonary disease (COPD). Firstly there will be a definition of COPD and COPD exacerbation. Then there will be a short discussion of how the patient’s data relates to pathophysiology of COPD exacerbation. This information is used to decide what the patient’s first two priority problems are, and two nurse interventions used to best treat those problems.
Chronic obstructive pulmonary disease (COPD) is an umbrella term used to refer to chronic, progressive diseases affecting the respiratory system including chronic bronchitis and emphysema. COPD is characterised by inflammation, loss of muco-ciliary clearance, fibrosis and loss of elastic recoil in the lung parenchyma. Inflammation increases mucous secretions that cannot be efficiently cleared from the airway due to the destruction of cilia. Damage to lungs and excessive mucous reduces airflow, gas exchange and expiratory volume leading to gas trapping. These changes cause the patient to develop the dyspnoea, cough and sputum production characteristic of COPD (Burt & Corbridge, 2013, p. 34-35).
The Global Initiative for Chronic Obstructive Lung Disease (GOLD) defines COPD exacerbation as an acute event characterised by an aggravation of the above symptoms beyond normal variations resulting in changes to the patient’s medications. Furthermore, an exacerbation is often indicative of disease progression (2014, p. 40). COPD exacerbation is most commonly caused by bacterial and/or viral infection (GOLD, 2014, p. 40).
The patient in the case study has been admitted to hospital with an infective exacerbation of his COPD. Respiratory infection causes increased inflammation an...
... middle of paper ...
...n assisting sputum production and relieving breathlessness (2008, p. 54).
The second intervention to improve gas exchange related to ineffective airway clearance is the use of a positive expiratory pressure device (PEP). PEP devices work by providing constant backwards pressure on the airways during expiration.
In review conducted by the Cochrane Collaboration, it was found that performing airway clearance techniques on patients with an acute episode of COPD reduced the likelihood of mechanical ventilation, as well as the length of time ventilation was needed (2012, p. 2).
While secretion clearance alone may not offer the patient long-term benefit, it is clearly important for maximising patient comfort.
- The patient will continue to secrete mucous due to medical condition exacerbated by infection, however it will provide patient comfort in the short term.
The presented case is of a patient named R.S. who has a smoking history of many years, which can be directly tied to his development of chronic bronchitis, a chronic obstructive pulmonary disease (COPD) specified as Type B. It is estimated that in 90% of chronic bronchitis or “blue bloaters”, cigarette smoking is the major cause. Chronic bronchitis involves persistent and irreversible airway obstruction, due to the constant inflammation of the bronchial mucosa, leading to hypertrophy and hyperplasia of bronchial glands. The latter exposes the individual to higher risks of bacterial infections; often colonization of organisms such as Streptococcus or Staphyloccocus pneumoniae can be exhibited. This is due to the lost or impaired function of mucociliary clearance action which results from the replacement of certain sections of ciliated columnar epithelium by squamous cells in the bronchi. (Copstead &Banasik, 546-547)
R.S. has chronic bronchitis. According to the UC San Francisco Medical Center “Chronic bronchitis is a common type of chronic obstructive pulmonary disease (COPD) in which the air passages in the lungs — the bronchi — are repeatedly inflamed, leading to scarring of the bronchi walls. As a result, excessive amounts of sticky mucus are produced and fill the bronchial tubes, which become thickened, impeding normal airflow through the lungs.” (Chronic Bronchitis 2015) There are many things that can be observed as clinical findings. R.S. will have a chronic cough that has lasted from 3 months to two years or more, and a lot of sputum. The sputum is due to
It incorporates dietary advising, exercise training, and mental guiding. There are also numerous surgical treatment alternatives. For example, the removal of nasal polyps that block breathing, oxygen treatment to prevent pulmonary hypertension, endoscopy and lavage to suction mucus from airways, the surgical insertion of a feeding tube may be important to convey supplements while sleeping. In cases where life-threatening lung complexities arise, a lung transplant may be viewed as an option.
Mrs. Jones has a history of COPD. She was already taking albuterol for her illness and it was ineffective when she took it that day. Mrs. Jones had been a smoker but had quit several years ago. According to Chojnowski (2003), smoking is a major causative factor in the development of COPD. Mrs. Jones's primary provider stated that she had a mixed type of COPD. The Global Initiative for Chronic Obstructive Lung Disease (GOLD) was established to address the growing problem of COPD. The GOLD standards identify three conditions that contribute to the structural changes found in COPD: Chronic bronchiolitis, emphysema, and chronic bronchitis. A mixed diagnosis means that the patient has a combination of these conditions (D., Chojnowski, 2003). Mrs. Jones chronically displayed the characteristic symptoms of COPD. "The characteristic symptoms are cough, sputum production, dyspnea on exertion, and decreased exercise tolerance." (D., Chojnowski, 2003, p. 27).
Introduction BiPAP is a form of noninvasive mechanical ventilation used in patients with acute respiratory failure. Many of these patients go on noninvasive ventilation due to COPD exacerbations that are infectious, with congestive heart failure, and ventilator parameters based on their clinical assessment and changes in arterial blood gases. Two different studies were conducted on COPD patients, using a BiPAP machine to improve exacerbations and their activities of daily living. There are many positive outcomes for using these noninvasive ventilators, however when used incorrectly, negative outcomes or no changes at all are always possible. Positive Use for COPD Exacerbations
Chronic obstructive pulmonary disease, better known as COPD, is a disease that affects a person’s ability to breathe normal. COPD is a combination of two major lung diseases: emphysema and chronic bronchitis. Bronchitis affects the bronchioles and emphysema affects the alveoli.
Chronic obstructive pulmonary disease or COPD is a group of progressive lung diseases that block airflow and make it hard to breathe. Emphysema and chronic bronchitis are the most common types of COPD (Ignatavicius & Workman, 2016, p 557). Primary symptoms include coughing, mucus, chest pain, shortness of breath, and wheezing (Ignatavicius & Workman, 2016, p.557). COPD develops slowly and worsens over time if not treated during early stages. The disease has no cure, but medication and disease management can slow its progress and make one feel better (NIH, 2013)
The purpose of this essay is to explore nursing care priorities for a patient with a common health condition. A common health condition is a disease or condition which occurs most often within a population. The author has chosen scenario 3 for this essay and will describe the nursing assessment and care planning provided to a patient with Chronic Obstructive Pulmonary Disease (COPD). The WHO definition of COPD is a lung disease which has a chronic obstruction of the airways that impedes normal breathing and is not fully reversible (). According to), there are estimated to be over 3 million people in the UK with COPD. It is common in later life and there are approximately 25,000 deaths each year, with 15% of COPD being work related (The identity of the patient will remain anonymous in adherence with the Nursing and Midwifery Council, Code of Conduct on patient confidentiality (). However, the patient will be referred to as Mr B in this essay. The author has chosen the priority of eating and drinking for Mr B. Patients with COPD are at increased risk of malnutrition and nurses must make certain they screen patients and offer advice or refer as necessary (). If this priority is managed well it will have a positive effect on the other priorities (, 2012). In accordance with NICE Guideline 101 (), the treatment and care provided should consider each persons’ individual requirements and preference. Care and treatment should take into account people’s individual needs and choices. To allow people to reach informed decisions there must be good communication, supported by evidence-based practice (). This essay will provide an evidence based discussion on how care will be implemented in relation to Mr B and his eating and drin...
My disease is Streptococcal pneumonia or pneumonia is caused by the pathogen Streptococcus pneumoniae. Streptococcus pneumoniae is present in human’s normal flora, which normally doesn’t cause any problems or diseases. Sometimes though when the numbers get too low it can cause diseases or upper respiratory tract problems or infections (Todar, 2008-2012). Pneumonia caused by this pathogen has four stages. The first one is where the lungs fill with fluid. The second stage causes neutrophils and red blood cells to come to the area which are attracted by the pathogen. The third stage has the neutrophils stuffed into the alveoli in the lungs causing little bacteria to be left over. The fourth stage of this disease the remaining residue in the lungs are take out by the macrophages. Aside from these steps pneumonia follows, if the disease should persist further, it can get into the blood causing a systemic reaction resulting in the whole body being affected (Ballough). Some signs and symptoms of this disease are, “fever, malaise, cough, pleuritic chest pain, purulent or blood-tinged sputum” (Henry, 2013). Streptococcal pneumonia is spread through person-to-person contact through aerosol droplets affecting the respiratory tract causing it to get into the human body (Henry, 2013).
Carone M, D. C. ( 2007). Clinical Challenges In COPD[e-book]. (Oxford: Clinical Pub) Retrieved March 24, 2014, from (EBSCOhost).
#2 When the patients is in upright position and oxygen delivery is improved and it helps to decrease airway collapse, dyspnea, and work of breathing.
Chronic obstructive pulmonary disease (COPD) is preventable disease that has a detrimental effects on both the airway and lung parenchyma (Nazir & Erbland, 2009). COPD categorises emphysema and chronic bronchitis, both of which are characterised by a reduced maximum expiratory flow and slow but forced emptying of the lungs (Jeffery 1998). The disease has the one of the highest number of fatalities in the developed world due to the ever increasing amount of tobacco smokers and is associated with significant morbidity and mortality (Marx, Hockberger & Walls, 2014). Signs and symptoms that indicate the presence of the disease include a productive cough, wheezing, dyspnoea and predisposing risk factors (Edelman et al., 1992). The diagnosis of COPD is predominantly based on the results of a lung function assessment (Larsson, 2007). Chronic bronchitis is differentiated from emphysema by it's presentation of a productive cough present for a minimum of three months in two consecutive years that cannot be attributed to other pulmonary or cardiac causes (Marx, Hockberger & Walls, 2014) (Viegi et al., 2007). Whereas emphysema is defined pathologically as as the irreversible destruction without obvious fibrosis of the lung alveoli (Marx, Hockberger & Walls, 2014) (Veigi et al., 2007).It is common for emphysema and chronic bronchitis to be diagnosed concurrently owing to the similarities between the diseases (Marx, Hockberger & Walls, 2014).
Hinkle, Janice, and Kerry Cheever. “Management of Patients with Chronic Pulmonary Disease." Textbook of Medical-Surgical Nursing, 13th Ed. Philadelphia: Lisa McAllister, 2013. 619-630. Print.
COPD Chronic Obstructive Pulmonary Disease is the name of a collection of lung diseases. Such as chronic bronchitis, and emphysema. 83% of the deaths caused by COPD are caused by smoking. Lung cancer, coughing, wheezing, and dying? Isn’t that what you think of when you hear smoking? You’re thinking yeah, I hear this all the time, I know what smoking does to you. But it does a lot more than just screw up your respiratory system. It messes everything up. Let’s start with skin, since this day and age everyone is obsessed with outer beauty. Smoking reduces the amount of oxygen that reaches that precious layer of yours. Causing it to become ashen and grey. Speeding up the aging process and increasing the likelihood of you looking like a withering
Chronic Obstructive Pulmonary Disease, or COPD is an umbrella term used to describe a combination of lung diseases. COPD (in the US) most commonly includes two main diseases, Emphysema and Chronic Bronchitis. COPD is a progressive disease that becomes worse over time. There is no known cure for COPD, but treatments are available to maintain quality of life. Chronic Obstructive Pulmonary Disease causes coughing fits that produce large amounts of phlegm as the bronchioles become plugged up with mucus. “COPD is not simply a "smoker's cough" but an under-diagnosed, life-threatening lung disease.” (As stated by the WHO, World Health Organization). Chronic Obstructive Pulmonary Disease affects more than 60 million people worldwide. In 2005 alone, more than 3 million people died from COPD. (2005, WHO) Those most at risk are smokers, women, especially where biomass fuel is used in the home, miners, those with a history of asthma and individuals who are unemployed, lower income, divorced, separated or widowed. Two of the elements most widely interchanged with the term COPD are, Emphysema and chronic bronchitis. These are entirely different diseases with their own diagnosis. Though most health organizations categorize them as COPD or COPD related, some institutions do not.